For example, FGF21 lessened tau hyperphosphorylation and oxidative stress in cellular and rat models of AD; its beneficial effects involved the inhibition of the PP2A/MAPKs/HIF-1α pathway [216] (Table 2). This evidence concerns the gene MAPT and Alzheimer disease.